Cadila Health

BSE: 532321 | NSE: CADILAHC

Cadila Health (CIN: L24230GJ1995PLC025878) operates in the Pharmaceuticals industry and has been listed in the stock market since 27th Apr 2000. It currents trades on NSE with symbol CADILAHC and on BSE with scrip code 532321.
The registered office of the company is Zydus Corporate Park, Scheme No. 63, Survey No. 536, Khoraj (Gandhinagar), Sarkhej - Gandhinagar Highway, Nr. Vaishnodevi Circle,Ahmedabad,Gujarat,382481.

The management team of Cadila Health is led by Mr. Pankaj R. Patel who is the Non-Executive - Non Independent Director-Chairperson related to Promoter. Other members of the management team consist of Mr. Sharvil P. Patel (Designation:Executive Director), Nitin D Parekh (Designation:Chief Financial Officer), Mr. Ganesh N. Nayak (Designation:Executive Director), Mrs. Dharmishtaben N. Raval (Designation:Non-Executive - Independent Director), Mr. Mukesh M. Patel (Designation:Non-Executive - Non Independent Director), Mr. Apurva S. Diwanji (Designation:Non-Executive - Independent Director), Mr. Nitin R. Desai (Designation:Non-Executive - Independent Director), Mr. Bhadresh K. Shah (Designation:Non-Executive - Independent Director), Dhaval N. Soni (Designation:Company Secretary & Compliance Officer), .

The price and other financial information of Cadila Health is as below -

Symbol is not Traded Today for BSE

Volume: 18,72,352.00

M. Cap: 25,879.00

P/E: 20.70

Prev. Close: 256.85

Day

L H 248.65 264.75

52 Wk

L H 202.00 352.60

Stock Price Chart

Expiry Date	Open Price	High Price	Low Price	Prev Close	Last Price	Volume	Turnover Lacs	Underlying Value
30-04-2020	263.10	267.60	249.60	259.90	255.00	708.00	4,010.82	252.00
25-06-2020				260.90				252.00
28-05-2020				260.00	260.00			252.00

Calls				30 Apr 2020	Puts
OI (Delta OI)	LTP (Change)	Intrinsic Value	Time Value	Strike Price	Time Value	Intrinsic Value	LTP (Change)	OI (Delta OI)
-	-	-	-	170	-	-	-	-
-	-	-	-	175	-	-	-	-
-	-	-	-	180	-	-	-	-
-	-	-	-	185	-	-	-	-
-	-	-	-	190	-	-	-	-
-	-	-	-	195	-	-	-	-
-	-	-	-	200	-	-	-	-
-	-	-	-	205	-	-	-	-
-	-	-	-	210	-	-	-	-
-	-	-	-	215	-	-	-	-
-	-	-	-	220	9.15	0	9.15 (+8.95)	4,400 (+4,400.00)
-	-	-	-	225	-	-	-	-
-	-	-	-	230	-	-	-	-
-	-	-	-	235	-	-	-	-
-	-	-	-	240	-	-	-	-
-	-	-	-	245	-	-	-	-
-	-	-	-	250	14.8	0	14.80 (-3.20)	6,600 (-2,200.00)
-	-	-	-	255	-	-	-	-
2,200 (-)	25.00 (-25.00)	0	25	260	11.8	7.2	19.00 (-19.00)	4,400 (-)
-	-	-	-	265	-	-	-	-
4,400 (+2,200.00)	14.80 (-11.20)	0	14.8	270	7.8	17.2	25.00 (-25.00)	4,400 (-)
-	-	-	-	275	-	-	-	-
17,600 (+2,200.00)	10.00 (-5.50)	0	10	280	-	-	-	-
-	-	-	-	285	-	-	-	-
-	-	-	-	290	-	-	-	-
-	-	-	-	295	-	-	-	-
24,200 (+4,400.00)	10.00 (+1.70)	0	10	300	0.8	47.2	48.00 (-48.00)	2,200 (-)
-	-	-	-	305	-	-	-	-
30,800 (-)	6.25 (-0.75)	0	6.25	310	-	-	-	-
2,200 (+2,200.00)	2.30 (+1.20)	0	2.3	315	-	-	-	-
17,600 (-)	11.20 (-11.20)	0	11.2	320	-27.2	67.2	40.00 (-40.00)	17,600 (-)
-	-	-	-	325	-	-	-	-
6,600 (+2,200.00)	5.50 (-0.50)	0	5.5	330	-	-	-	-
-	-	-	-	335	-	-	-	-

Shareholding Pattern

Category	No. of shares	Percent(%)
Promoters	76,65,34,434	74.88
Foreign Institutions	4,68,44,033	4.58
Central Government	12,95,416	0.13
Others	2,11,79,410	2.07
NBFC and Mutual Funds	7,27,52,280	7.11
General Public	5,86,82,561	5.73
Financial Institutions	5,64,54,466	5.51
Total	1,02,37,42,600	100.01

NSE Trade Data

Trade Snapshot

VWAP	256.06
Face Value	1.00
Traded Volume (shares)	18,72,352.00
Traded Value (lacs)	4,794.34
Free Float Market Cap (Crs)	6,467.49
52 week high	352.60
52 week low	202.00
Lower Price Band	231.20
Upper Price Band	282.50

Security-wise Delivery Position

Quantity Traded	18,72,352.00
Deliverable Quantity (gross across client level)	5,50,007.00
% of Deliverable Quantity to Traded Quantity	29.38 %

Value at Risk (VaR in %)

Security VaR	16.81
Index VaR	-
VAR Margin	16.81
Extreme Loss Rate	5.00
Adhoc Margin	4.43
Applicable Margin Rate	26.24

Financial Data

Consolidated

Figures in crore	2019	2018	2017
Net Sales	13,165.60	11,904.90	9,376.50
Operating Profit	3,174.20	2,941.90	2,029.80
Other Income	201.10	113.20	128.40
Interest	193.50	91.10	44.60
Depreciation	598.60	538.80	373.30
Profit Before Tax	2,382.10	2,312.00	1,611.90
Tax	530.30	564.40	128.90
Profit After Tax	1,851.80	1,747.60	1,483.00
Share Capital	102.40	102.40	102.40
Reserves	10,283.90	8,642.10	6,857.60
Net Worth	10,386.30	8,744.50	6,960.00
Loans	8,158.80	5,616.30	5,421.20
Gross Block	15,702.30	9,349.10	8,102.90
Investments	673.50	745.70	434.80
Cash	649.30	1,314.90	1,543.50
Debtors	3,950.80	3,206.30	2,277.50
Net Working Capital	6,163.60	5,796.30	4,804.10
Operating Profit Margin (%)	24.11	24.71	21.65
Net Profit Margin (%)	14.07	14.68	15.82
Earning Per Share (Rs)	18.05	17.34	14.53
Dividend (%)	350.00	350.00	320.00
Dividend Payout	358.30	0.00	327.60

Standalone

Figures in crore	2019	2018	2017
Net Sales	6,492.70	5,809.90	3,230.70
Operating Profit	2,366.70	1,854.20	904.20
Other Income	611.60	207.90	583.10
Interest	88.40	63.90	11.10
Depreciation	349.80	293.10	250.90
Profit Before Tax	1,928.50	1,497.20	642.20
Tax	326.40	406.40	-19.70
Profit After Tax	1,602.10	1,090.80	661.90
Share Capital	102.40	102.40	102.40
Reserves	8,854.10	7,643.10	6,515.90
Net Worth	8,956.50	7,745.50	6,618.30
Loans	3,209.20	2,955.30	3,010.10
Gross Block	5,159.40	4,515.70	3,896.30
Investments	4,724.90	3,618.10	3,923.70
Cash	106.30	183.80	16.80
Debtors	2,087.90	1,255.10	929.00
Net Working Capital	3,846.30	3,743.30	2,674.30
Operating Profit Margin (%)	36.45	31.91	27.99
Net Profit Margin (%)	24.68	18.77	20.49
Earning Per Share (Rs)	15.65	10.65	6.45
Dividend (%)	350.00	350.00	320.00
Dividend Payout	358.30	0.00	327.60

Dividend Declared (₹)

The company has declared dividend 15 times between 18 Jun 2001 and 23 Mar 2020, totaling Rs. 76.00 so far. The most recent dividend was declared on 23 Mar 2020 for Rs. 3.5.

Bonus History
Date	Ratio
05 Apr 2010	issue 1:2

Financial Data Graph

The peers of Cadila Health are AUROPHARMA, LUPIN and GLENMARK. You can get more detailed information on those company by clicking on the respective names.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*

Popular Comments

No comment posted for this article.

Post your comment